BlackRock’s BELLUS Health Inc. BLU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-868,239
Closed -$6.25M 5650
2023
Q1
$6.25M Sell
868,239
-52,780
-6% -$409K ﹤0.01% 3537
2022
Q4
$7.57M Buy
921,019
+69,939
+8% +$652K ﹤0.01% 3523
2022
Q3
$8.99M Buy
851,080
+109,983
+15% +$1.17M ﹤0.01% 3482
2022
Q2
$6.85M Sell
741,097
-60,043
-7% -$491K ﹤0.01% 3685
2022
Q1
$5.51M Buy
801,140
+241,327
+43% +$1.55M ﹤0.01% 3903
2021
Q4
$4.51M Buy
+559,813
New +$3.72M ﹤0.01% 4035
2021
Q2
Sell
-1
Closed 5594
2021
Q1
$0 Sell
1
-3,965
-100% -$15K ﹤0.01% 5387
2020
Q4
$12K Buy
3,966
+95
+2% +$257 ﹤0.01% 4837
2020
Q3
$9K Buy
+3,871
New +$11K ﹤0.01% 4811

Other funds holding BLU

BlackRock's BLU Position: Q2 2023 in Review

BlackRock sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 868,239 shares — an estimated $6.25M sold.

BlackRock first reported a position in BLU in Q3 2020 and held it in 9 quarters. The position peaked at $8.99M in Q3 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • BlackRock reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • BlackRock sold 868,239 BELLUS Health Inc. shares in Q2 2023, an estimated $6.25M.
  • BlackRock first reported a position in BELLUS Health Inc. in Q3 2020 and held it in 9 quarters.
  • BlackRock's BELLUS Health Inc. position peaked at $8.99M in Q3 2022.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on BlackRock's 13F filing for Q2 2023, filed 11 Aug 2023.